Hearing of Dr Christophe Grosset by the Senate Cancer Study Group

On March 20, Dr Christophe Grosset,Director of Research at Inserm and head of theteam 6 MIRCADE at BRICwill be visiting the French Senate at the request of Senator Florence Lassarade, a member of the Social Affairs Commission and Chair of the “Cancer” study group. He will be appearing before this study group to discuss his research using artificial intelligence to study the architecture of liver tumor tissue in children, and to develop new therapeutic solutions for children with cancer. This work, funded by the Institut National du Cancer and several charities, is being carried out in close partnership with Baudouin de Senneville, mathematician and CNRS Research Director at the Institut de Mathématiques de Bordeaux, and Jonathan Baptista, co-founder of the DeepLife company.